Evidence map›Paper›PMID 29124935›Full record

ArticleThe Journal of organic chemistry2017

Enzymatic and Chemoenzymatic Syntheses of Disialyl Glycans and Their Necrotizing Enterocolitis Preventing Effects.

Hai Yu, Xuebin Yan, Chloe A Autran, Yanhong Li, Sabrina Etzold, Joanna Latasiewicz, Bianca M Robertson, Jiaming Li, Lars Bode, Xi Chen

Abstract read
In one paragraph

Article in The Journal of organic chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Enzymatic Synthesis of Glycans and Glycoconjugates.Advances in biochemical engineering/biotechnology · 2021
    Review
  7. Tandem sialoglycan-binding modules in aThe Journal of biological chemistry · 2020
    Article
  8. Catalytic Cycle ofBiochemistry · 2020
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Redox-Controlled Site-Specific α2-6-Sialylation.Journal of the American Chemical Society · 2019
    Article
  17. Review
  18. Review
  19. Synthesis ofFrontiers in immunology · 2019
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Hai YuGlycohub, Inc. , 4070 Truxel Road, Sacramento, California 95834, United States.
Xuebin YanDepartment of Chemistry, University of California , One Shields Avenue, Davis, California 95616, United States.
Chloe A AutranDivision of Neonatology and Division of Gastroenterology and Nutrition, Department of Pediatrics, and Larsson-Rosenquist Foundation Mother-Milk-Infant Center of Research Excellence (LRF MoMI CoRE), University of California-San Diego , La Jolla, California 92093, United States.
Yanhong LiGlycohub, Inc. , 4070 Truxel Road, Sacramento, California 95834, United States.
Sabrina EtzoldDivision of Neonatology and Division of Gastroenterology and Nutrition, Department of Pediatrics, and Larsson-Rosenquist Foundation Mother-Milk-Infant Center of Research Excellence (LRF MoMI CoRE), University of California-San Diego , La Jolla, California 92093, United States.
Joanna LatasiewiczDivision of Neonatology and Division of Gastroenterology and Nutrition, Department of Pediatrics, and Larsson-Rosenquist Foundation Mother-Milk-Infant Center of Research Excellence (LRF MoMI CoRE), University of California-San Diego , La Jolla, California 92093, United States.
Bianca M RobertsonDivision of Neonatology and Division of Gastroenterology and Nutrition, Department of Pediatrics, and Larsson-Rosenquist Foundation Mother-Milk-Infant Center of Research Excellence (LRF MoMI CoRE), University of California-San Diego , La Jolla, California 92093, United States.
Jiaming LiDepartment of Chemistry, University of California , One Shields Avenue, Davis, California 95616, United States.
Lars BodeDivision of Neonatology and Division of Gastroenterology and Nutrition, Department of Pediatrics, and Larsson-Rosenquist Foundation Mother-Milk-Infant Center of Research Excellence (LRF MoMI CoRE), University of California-San Diego , La Jolla, California 92093, United States.
Xi ChenDepartment of Chemistry, University of California , One Shields Avenue, Davis, California 95616, United States.ORCID 0000-0002-3160-614X
University of California San Diego · USUniversity of California, Davis · USZhejiang University · CNZhengzhou University · CN

Funding

Oligosaccharides as antimicrobials and prebioticsR01HD065122 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHEN, XI · 2010 to 2013
$1.8M
Disialyl oligosaccharides as Necrotizing Enterocolitis therapeuticsR43HD087077 · NICHD · GLYCOHUB, INC. · PI BODE, LARS, YU, HAI · 2015 to 2015
$200k
NICHD NIH HHS R01 HD065122NICHD NIH HHS R43 HD087077
6 · The paper itself

Abstract

Necrotizing enterocolitis (NEC) is one of the most common and devastating intestinal disorders in preterm infants. Therapies to meet the clinical needs for this special and highly vulnerable population are extremely limited. A specific human milk oligosaccharide (HMO), disialyllacto-N-tetraose (DSLNT), was shown to contribute to the beneficial effects of breastfeeding as it prevented NEC in a neonatal rat model and was associated with lower NEC risk in a human clinical cohort study. Herein, gram-scale synthesis of two DSLNT analogs previously shown to have NEC preventing effect is described. In addition, four novel disialyl glycans have been designed and synthesized by enzymatic or chemoenzymatic methods. Noticeably, two disialyl tetraoses have been produced by enzymatic sialylation of chemically synthesized thioethyl β-disaccharides followed by removal of the thioethyl aglycon. Dose-dependent and single-dose comparison studies showed varying NEC-preventing effects of the disialyl glycans in neonatal rats. This study helps to refine the structure requirement of the NEC-preventing effect of disialyl glycans and provides important dose-dependent information for using DSLNT analogs as potential therapeutics for NEC prevention in preterm infants.

Indexed as

AnimalsEnterocolitis, NecrotizingHumansInfant, NewbornModels, AnimalOligosaccharidesPolysaccharidesRatsdisialyllacto-N-tetraoseOligosaccharidesPolysaccharides

Identifiers

PMID29124935
PMCPMC5764747
OpenAlexW2767631527

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.